<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">642587</article-id><article-id pub-id-type="doi">10.17816/dv642587</article-id><article-id pub-id-type="edn">XOQZTU</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Role of a sebum-regulating complex in correcting epidermal barrier parameters in patients with acne</article-title><trans-title-group xml:lang="ru"><trans-title>Роль себорегулирующего комплекса в коррекции показателей эпидермального барьера у пациентов с акне</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5936-6232</contrib-id><contrib-id contrib-id-type="spin">5832-9510</contrib-id><name-alternatives><name xml:lang="en"><surname>Zaslavsky</surname><given-names>Denis V.</given-names></name><name xml:lang="ru"><surname>Заславский</surname><given-names>Денис Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>venerology@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5056-374X</contrib-id><contrib-id contrib-id-type="spin">1191-8991</contrib-id><name-alternatives><name xml:lang="en"><surname>Taganov</surname><given-names>Alexey V.</given-names></name><name xml:lang="ru"><surname>Таганов</surname><given-names>Алексей Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><email>matis87177@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6942-2880</contrib-id><contrib-id contrib-id-type="spin">3783-8565</contrib-id><name-alternatives><name xml:lang="en"><surname>Kozlova</surname><given-names>Daria V.</given-names></name><name xml:lang="ru"><surname>Козлова</surname><given-names>Дарья Васильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>dashauchenaya@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-5987-8099</contrib-id><contrib-id contrib-id-type="spin">9685-5678</contrib-id><name-alternatives><name xml:lang="en"><surname>Kulikova</surname><given-names>Svetlana Yu.</given-names></name><name xml:lang="ru"><surname>Куликова</surname><given-names>Светлана Юрьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>svet22_07@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2017-090X</contrib-id><contrib-id contrib-id-type="spin">8553-8384</contrib-id><name-alternatives><name xml:lang="en"><surname>Khvedelidze</surname><given-names>Mikhail G.</given-names></name><name xml:lang="ru"><surname>Хведелидзе</surname><given-names>Михаил Георгиевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><email>sussll@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-1932-3373</contrib-id><contrib-id contrib-id-type="spin">4777-1850</contrib-id><name-alternatives><name xml:lang="en"><surname>Lyamina</surname><given-names>Ekaterina A.</given-names></name><name xml:lang="ru"><surname>Лямина</surname><given-names>Екатерина Антоновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>katerina_lyamina00@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-9064-4022</contrib-id><contrib-id contrib-id-type="spin">6544-1989</contrib-id><name-alternatives><name xml:lang="en"><surname>Manafova</surname><given-names>Gulay A.</given-names></name><name xml:lang="ru"><surname>Манафова</surname><given-names>Гюлай Алисафаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>gul-manafova2017@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-8960-1449</contrib-id><name-alternatives><name xml:lang="en"><surname>Dyatlov</surname><given-names>Kirill D.</given-names></name><name xml:lang="ru"><surname>Дятлов</surname><given-names>Кирилл Дмитриевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>thorimsson@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-1031-720X</contrib-id><contrib-id contrib-id-type="spin">7831-6314</contrib-id><name-alternatives><name xml:lang="en"><surname>Aletskiy-Milyutin</surname><given-names>Nikolay N.</given-names></name><name xml:lang="ru"><surname>Алецкий-Милютин</surname><given-names>Николай Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>aletskiy.nn@gmail.com</email><xref ref-type="aff" rid="aff5"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Saint-Petersburg State Pediatric Medical University</institution></aff><aff><institution xml:lang="ru">Санкт-Петербургский государственный педиатрический медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Pierre Wolkenstein Skin Diseases Clinic</institution></aff><aff><institution xml:lang="ru">Клиника Кожных Болезней Пьера Волькенштейна</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Granov Russian Research Center of Radiology and Surgical Technologies</institution></aff><aff><institution xml:lang="ru">Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">North-Western State Medical University named after I.I. Mechnikov</institution></aff><aff><institution xml:lang="ru">Северо-Западный государственный медицинский университет имени И.И. Мечникова</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Joint-Stock Company Wertex</institution></aff><aff><institution xml:lang="ru">Акционерное общество «Вертекс»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-07-27" publication-format="electronic"><day>27</day><month>07</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-07-31" publication-format="electronic"><day>31</day><month>07</month><year>2025</year></pub-date><volume>28</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>267</fpage><lpage>277</lpage><history><date date-type="received" iso-8601-date="2024-12-07"><day>07</day><month>12</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-06-18"><day>18</day><month>06</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2028-07-31"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/642587">https://rjsvd.com/1560-9588/article/view/642587</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> Recent studies consider acne vulgaris as a disease associated with epidermal barrier dysfunction. Restoring the epidermal barrier has been recognized as a key aspect of acne management, making the development of topical products that address both clinical manifestations of acne and barrier disruption a relevant task.</p> <p><bold>AIM:</bold> To assess the efficacy and safety of a topical formulation containing an innovative sebum-regulating complex in adolescents with mild acne.</p> <p><bold>METHODS:</bold> It was a prospective, single-center observational study conducted at the Federal State Budgetary Educational Institution of Higher Education St. Petersburg State Pediatric Medical University (Russia) from May to December 2024. The study included 30 patients (13 boys and 17 girls; mean age, 14.5 years) with mild acne whose legal guardians provided informed consent. Participants applied a cosmetic product regimen twice daily for 84 days. Four study visits were scheduled, during which investigators assessed lesion counts and measured skin hydration, sebum levels, pH, and erythema using the Multi Skin Test Center 750 device (Germany). Adverse events, quality of life, and satisfaction with topical products were also evaluated.</p> <p><bold>RESULTS:</bold> All participants completed the study as planned. Partial or complete lesion regression was recorded in all cases. The mean number of comedones, papules/pustules, and inflammatory lesions decreased by 82.9%, 86.2%, and 91.2%, respectively. Facial erythema intensity was reduced by 21%; skin hydration increased by 3.4%; sebum levels decreased by 37.7%; and skin pH shifted 12.6% toward acidity. Quality of life improved by 51.7% according to the CDLQI questionnaire. No adverse reactions to the studied topical products were reported. Overall, 97% (29/30) of participants rated their experience as excellent.</p> <p><bold>CONCLUSION:</bold> A cosmetic product containing a sebum-regulating complex can be recommended as adjunctive or standalone skincare for adolescents with mild acne. This formulation is not only effective and safe for managing acne lesions but also improves epidermal barrier function.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Современные исследования рассматривают вульгарные акне как заболевание, сопровождаемое развитием дефектов эпидермального барьера. Восстановление показателей эпидермального барьера признано одним из важнейших аспектов в контексте лечения акне, поэтому поиск наружных средств, позволяющих успешно бороться с клиническими проявлениями акне и восстанавливать нарушения эпидермального барьера, является актуальной задачей.</p> <p><bold>Цель исследования</bold> ― определение эффективности и безопасности средств с инновационным себорегулирующим комплексом у подростков с акне лёгкой степени тяжести.</p> <p><bold>Методы.</bold> На базе ФГБОУ ВО СПбГПМУ Минздрава России с мая по декабрь 2024 года проведена проспективная одноцентровая наблюдательная программа с участием 30 пациентов (13 мальчиков, 17 девочек, средний возраст 14,5 года) с акне лёгкой степени тяжести, законные представители которых подписали добровольное информированное согласие. Участники применяли в течение 84 дней 2 раза в сутки комплекс косметических средств. Программа включала четыре визита, на каждом проводились объективный осмотр с подсчётом элементов сыпи, оценка влажности, сальности, pH, эритемы кожи с помощью аппарата Multi Skin Test Center 750 (Германия), сбор данных о нежелательных явлениях, оценка качества жизни и удовлетворённости от применения наружных средств.</p> <p><bold>Результаты.</bold> Пациенты завершили участие в программе согласно плану. У всех регистрировали частичный и полный регресс высыпаний. Среднее количество комедонов в группе наблюдения снизилось на 82,9%; папул/пустул ― на 86,2%, воспалительных элементов ― на 91,2%. Наблюдалось снижение интенсивности эритемы кожи лица на 21%, повышение увлажнённости на 3,4%, снижение интенсивности сальности на 37,7%, смещение кислотности в кислую сторону на 12,6%, улучшение качества жизни по данным опросника CDLQI на 51,7%. Нежелательных реакций на фоне применения исследуемых наружных средств не отмечалось, 97% (29/30) пациентов оценили опыт участия в программе как отличный.</p> <p><bold>Заключение.</bold> Комплекс косметических средств с себорегулирующим комплексом в составе может быть рекомендован в качестве дополнительного к терапии или изолированного уходового режима, отвечающего всем требованиям эффективности и безопасности, у подростков с акне лёгкой степени тяжести. Действие данного комплекса косметических средств направлено не только на борьбу с клиническими проявлениями акне, но также способно восполнить дефекты эпидермального барьера.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acne vulgaris</kwd><kwd>topical therapy</kwd><kwd>dermocosmetics</kwd><kwd>epidermal barrier restoration</kwd><kwd>sebum regulation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вульгарные акне</kwd><kwd>наружная терапия</kwd><kwd>дерматокосметика</kwd><kwd>восстановление эпидермального барьера</kwd><kwd>себорегуляция</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">АО «Вертекс»</institution></institution-wrap><institution-wrap><institution xml:lang="en">JSC WERTEX</institution></institution-wrap></funding-source></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Murashkin NN, Ivanov AM, Zaslavsky DV, Kamilova NA. Studies on effectiveness and safety of system retinoids use in therapy of adolescent acne. Vestnik dermatologii i venerologii. 2010;(5):112–116. EDN: MXFMXT</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Gorlanov IA, Levina LM, Milyavskaya IR, Zaslavsky DV. Pediatric dermatology. A guide for doctors. Moscow: GEOTAR-Media; 2022. 676 р. (In Russ.) doi: 10.33029/9704-6482-3-DDR-2022-1-676 EDN: NXIVTB</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Zaslavskiy DV, Sadykov AA, Okhlopkov VA, Nasyrov RA. Skin lesions in diseases of internal organs. An illustrated guide for doctors. Moscow: GEOTAR-Media; 2020. 352 р. (In Russ.) doi: 10.33029/9704-5379-7-РКО-2020-1-352 EDN: QPYULG</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Pappas A, Johnsen S, Liu JC, Eisinger M. Sebum analysis of individuals with and without acne. Dermatoendocrinol. 2009;1(3):157–161. doi: 10.4161/derm.1.3.8473</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Prakash C, Bhargava P, Tiwari S, et al. Skin surface ph in acne vulgaris: Insights from an observational study and review of the literature. J Clin Aesthet Dermatol. 2017;10(7):33–39.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Segger D, Aßmus U, Brock M, et al. Multicenter study on measurement of the natural pH of the skin surface. Int J Cosm Sci. 2008;30:75–75. doi: 10.1111/j.1468-2494.2007.00403_1.x</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Podwojniak A, Tan IJ, Sauer J, et al. Acne and the cutaneous microbiome: A systematic review of mechanisms and implications for treatments. J Eur Acad Dermatol Venereol. 2025;39(4):793–805. doi: 10.1111/jdv.20332</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zaslavsky DV, Barinova AN. Skin microbiome in atopic dermatitis and features of various background skin care. Medical Council. 2018;(2):170–176. doi: 10.21518/2079-701X-2018-2-170-176 EDN: YPSZYZ</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zaslavsky DV, Egorova YuS, Olovyanishnikov OV, Volkova NS. On the history and combined therapy of rosacea. Russian Journal of Clinical Dermatology and Venereology. 2009;7(3):80–84. EDN: QIZCKX</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Zaslavsky DV, Sobolev AV, Skrek SV, et al. Normalization of the epidermal barrier as a method of pathogenetic therapy of atopic dermatitis in children. Vestnik dermatologii i venerologii. 2021;97(5):52–65. doi: 10.25208/vdv1255 EDN: LQWQPS</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Schachner LA, Alexis AF, Andriessen A, et al. Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide-containing skincare. J Cosmet Dermatol. 2023;22(11):2902–2909. doi: 10.1111/jocd.15946</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Del Rosso JQ, Levin J. The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol. 2011;4(9):22–42.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lovászi M, Szegedi A, Zouboulis CC, Törőcsik D. Sebaceous-immunobiology is orchestrated by sebum lipids. Dermatoendocrinol. 2017;9:e1375636. doi: 10.1080/19381980.2017.1375636</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Araviyskaya ER, Murashkin NN, Ivanov RA. Acne vulgaris in adolescents: Scientific evidence for optimizing treatment regimens via dermatocosmetics. Current Pediatrics. 2024;23(5):285–294. doi: 10.15690/vsp.v23i5.2801 EDN: WSIFDF</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Araviiskaia ER, Samtsov AV, Sokolovskiy EV, et al. Revisiting the question of assessment by severity and classification of acne. Vestnik dermatologii i venerologii. 2022;98(6):48–54. doi: 10.25208/vdv1374 EDN: GYOPIW</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Schachner LA, Andriessen A, Benjamin L, et al. The many faces of pediatric acne: A practical algorithm for treatment, maintenance therapy, and skincare recommendations for pediatric acne patients. J Drugs Dermatol. 2023;22(6):539–545. doi: 10.36849/JDD.7440</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Olisova OYu. Differentiated approach to external acne therapy. Russian Journal of Skin and Venereal Diseases. 2024;27(1):55–68. doi: 10.17816/dv625969 EDN: ALOTCP</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Kang SY, Um JY, Chung BY, et al. Moisturizer in Patients with inflammatory skin diseases. Medicina (Kaunas). 2022;58(7):888. doi: 10.3390/medicina58070888</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kurokawa I, Layton AM, Ogawa R. Updated treatment for acne: Targeted therapy based on pathogenesis. Dermatol Ther. 2021;11(4):1129–1139. doi: 10.1007/s13555-021-00552-6</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Acne vulgar. Clinical recommendations. Russian Society of Dermatovenerologists and Cosmetologists; 2020. (In Russ.) Available at: https://www.rodv.ru Accessed: April 15, 2025.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Snarskaya ES, Olisova OY, Bratkovskaya AV, et al. Trifarotene: A new chapter in the treatment of acne. An overview of the data on efficacy and safety profile of a fourth-generation retinoid. Russian Journal of Skin and Venereal Diseases. 2024;27(2):219–230. doi: 10.17816/dv629838 EDN: JLQHRF</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Dall’oglio F, Tedeschi A, Fabbrocini G, et al. Cosmetics for acne: Indications and recommendations for an evidence-based approach. G Ital Dermatol Venereol. 2015;150(1):1–11.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Conforti C, Giuffrida R, Fadda S, et al. Topical dermocosmetics and acne vulgaris. Dermatol Ther. 2021;34(1):14436. doi: 10.1111/dth.14436</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1–1006.e30. doi: 10.1016/j.jaad.2023.12.017</mixed-citation></ref></ref-list></back></article>
